Controlling fever in patients with septic shock using external cooling
Official title: Intérêt du Traitement de la fièvre Par Refroidissement Externe Pour la Survie Des Patients ventilés en Choc Septique
Run by Centre Hospitalier Intercommunal Creteil · NCT04494074 · Data updated 2026-11-12
This study tests whether using external cooling to control fever helps people on ventilators with septic shock live longer and feel better compared to letting their fever continue.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 820 (estimated) |
| Sponsor | Centre Hospitalier Intercommunal Creteil Academic / other |
| Locations | 33 sites (Amiens and 32 other locations) |
| Status | Recruiting |
| Started | October 1, 2022 |
| Main results expected | December 1, 2028 |
| Study ends | December 1, 2028 |
| Registry record updated | September 21, 2026 |
| Trial ID | NCT04494074 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults with documented or suspected infections leading to septic shock, requiring mechanical ventilation and exhibiting fever.
✕Probably not a fit
Patients with recent cardiac arrest, acute brain injury, or those under 18 years old will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to compare two strategies for managing fever in mechanically ventilated patients suffering from septic shock. Participants will be randomly assigned to either continue with their fever or to receive external cooling to maintain normothermia. The study seeks to determine which approach leads to better outcomes, particularly focusing on mortality rates at 60 days. The trial builds on previous findings that suggest fever control may improve organ function and reduce mortality in severely ill patients.
Why it matters
Potential benefit: If successful, this study could improve survival rates and organ function in patients with septic shock.
How similar studies have gone: Previous studies have shown promising results with fever control in similar patient populations, indicating potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Documented or suspected infection either communautary or hospital acquired * Septic shock defined by the need for vasopressor and lactate\>2 mmol/l despite adequate fluid resuscitation (sepsis-3 definition) * Patients under invasive mechanical ventilation * Body core temperature\>38.3°C * Intravenous sedation or opioids * Ongoing antimicrobial treatment and/or intervention for infection source control * Attending physician confirms clinical equipoise without substantial risk if the patient participates in the trial * Informed consent of next of kin/other designated person before inclusion or procedure for inclusion in emergency situation Exclusion Criteria: * Cardiac arrest within previous 7 days * Acute brain injury within previous 7 days * Extensive burns or epidermal necrolysis * \<18 years old * Body core temperature \>41°C * Under legal guardianship * No affiliation with the French health-care system * Pregnancy * Participation in another interventional study with mortality as the primary endpoint * An investigator's decision not to resuscitate * Patient already recruited in the trial
Where it's running
-
CHU Amiens
Amiens, France Recruiting -
CHU Angers
Angers, France Recruiting -
CH Victor Dupouy
Argenteuil, France Recruiting -
Hôpital Nord Franche Comté
Belfort, France Recruiting -
CH Cholet
Cholet, France Recruiting -
Centre hospitalier intercommunal de Créteil
Créteil, France Recruiting
Show 27 more locations
-
CHD Dijon
Dijon, France Recruiting -
CHU Grenoble
Grenoble, France Recruiting -
GH Est Francilien
Jossigny, France Recruiting -
CHD Vendée
La Roche-sur-Yon, France Recruiting -
CHU Le Mans
Le Mans, France Recruiting -
CH Libourne
Libourne, France Recruiting -
Hôpital de la Croix-Rousse
Lyon, France Recruiting -
GRH Mulhouse
Mulhouse, France Recruiting -
CHU Hotel Dieu
Nantes, France Recruiting -
Hôpital Pasteur
Nice, France Recruiting -
Hopital Lariboisière - Réanimation Médicale
Paris, France Recruiting -
Hôpital Lariboisière -Réanimation chirurgicale
Paris, France Recruiting -
CHU La Milétrie Poitiers
Poitiers, France Recruiting -
CHU Charles Nicolle
Rouen, France Recruiting -
CHU Réunion Sud
Saint-Denis, France Recruiting -
Hôpital FOCH
Suresnes, France Recruiting -
CH BIGORRE SITE GESPE Tarbes
Tarbes, France Recruiting -
CHBA Vannes-Auray
Vannes, France Recruiting -
Centre Hospitalier Mignot
Versailles, France Recruiting -
Hôpital Henri Mondor
Créteil, France Active not recruiting -
CHU Kremlin Bicetre
Le Kremlin-Bicêtre, France Active not recruiting -
CH Lens
Lens, France Not yet recruiting -
Hôpital Saint Joseph Saint Luc
Lyon, France Not yet recruiting -
Hôpital Timone
Marseille, France Active not recruiting -
CHR Metz Hôpital de Mercy
Metz, France Not yet recruiting -
CHU Archet 1
Nice, France Active not recruiting -
CHU Reims
Reims, France Active not recruiting
Study contacts
- Study coordinator: Frédérique SCHORTGEN, MD
- Email: Frederique.schortgen@chicreteil.fr
- Phone: 01 57 02 34 11
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Adjunctive Fludrocortisone in Septic Shock on Hydrocortisone
In septic shock, this trial tests whether adding fludrocortisone (50 mcg or 100 mcg daily) to hydrocortisone improves survival and recovery compared with placebo.
-
Non-invasive hemodynamic guidance for sepsis care on medical wards
This trial tests whether guiding fluid and vasopressor therapy for sepsis using non-invasive hemodynamic measurements works better than standard care.
-
Reducing Endotoxin Burden in Septic Shock Patients on CRRT with the oXiris Filter
This trial tests whether using the oXiris hemofilter during continuous kidney replacement helps lower endotoxin levels in adults with septic shock who need CRRT.
-
Personalized Fluid Resuscitation in the Emergency Department
This pilot test checks if a quick, non-invasive stroke-volume assessment can help ED doctors tailor IV fluids for septic patients with low blood pressure.
-
Discordance between capillary refill time and oxygen use in septic shock
This study tests whether some septic shock patients can have a normal capillary refill time but still lack tissue oxygen use, to see if that mismatch relates to 28-day survival.
-
Targeting upper-normal magnesium to see if norepinephrine needs drop in septic shock
This trial tests whether keeping magnesium levels at the upper end of normal can reduce the amount and duration of norepinephrine needed in adults with septic shock.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.